LYNDSAY FUNKE: Open Payments
NPI 1164177069 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 69 payments from 13 companies in 2025. Trend: 2023 $1,067 · 2024 $1,054 · 2025 $1,353
Food & beverage: $1,253Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $442 |
| GENZYME CORPORATION | 10 | $180 |
| Regeneron Healthcare Solutions, Inc. | 10 | $164 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Verona Pharma, Inc. | 5 | $89 |
| Grifols USA, LLC | 5 | $85 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Actelion Pharmaceuticals US, Inc. | 3 | $65 |
| Electromed, Inc. | 5 | $59 |
| Viatris Specialty LLC | 2 | $38 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, Ohtuvayre, Prolastin-C Liquid, NUCALA, SMARTVEST, UPTRAVI.
Industry payments across MO — which companies pay providers there.
